KRTL BioTech

'Not a lot to like' — Analysts pan Tesla as the shares are slammed on poor results

'Not a lot to like' — Analysts pan Tesla as the shares are slammed on poor results

Wall Street analysts expressed frustration with the company's second quarter earnings report.